[Aggressive cytostatic treatment of osteogenic sarcoma in childhood (author's transl)].
D000293:Adolescent; D000367:Age Factors; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000473:pathology; D002648:Child; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use; D004317:Doxorubicin / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary; D008297:Male; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use; D009364:Neoplasm Recurrence, Local; D012516:Osteosarcoma / Q000188:drug therapy*; D014750:Vincristine / Q000627:therapeutic use
D000903:Antibiotics, Antineoplastic; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D008727:Methotrexate
Aggressive Zytostatikatherapie osteogener Sarkome im Kindesalter.